TEITUR TROPHICS
Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
TEITUR TROPHICS
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2020-01-01
Address:
Aarhus, Midtjylland, Denmark
Country:
Denmark
Website Url:
http://www.teiturtrophics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
28 M EUR
Technology used in webpage:
German Server Location
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Carcinotech
Carcinotech is focused on treating cancers and is based at the Roslin Innovation Centre on the outskirts of Edinburgh.
CHARM Therapeutics
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Design Therapeutics
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
Freeline
Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Kurve Therapeutics
Kurve Therapeutics engages in the development of treatments for neurodegenerative diseases.
Stalicla
STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.
VectivBio
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Volastra Therapeutics
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series A - Teitur Trophics
p53
p53 investment in Series A - Teitur Trophics
Sound Bioventures
Sound Bioventures investment in Series A - Teitur Trophics
Innovestor
Innovestor investment in Series A - Teitur Trophics
Industrifonden
Industrifonden investment in Series A - Teitur Trophics
Official Site Inspections
http://www.teiturtrophics.com Semrush global rank: 15.64 M Semrush visits lastest month: 1
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Teitur Trophics"
About Us – Teiturtrophics
About Us Teitur is Old Norse for happiness. Our ambition and commitment is to create new treatments for patients suffering from neurodegenerative diseases to help them live a longer, better and happier life. Our team is comprised of …See details»
Teitur Trophics - Crunchbase Company Profile & Funding
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.See details»
Teitur Trophics - LinkedIn
Teitur Trophics Biotechnology Research Teitur Trophics is a danish biotech company, developing novel treatments for neurodegenerative diseases.See details»
Teitur Trophics - 2025 Company Profile & Team - Tracxn
May 19, 2025 Teitur Trophics - Provider of neurodegenerative therapeutics development services. Raised a total funding of $30M over 2 rounds from 6 investors.See details»
Teitur Trophics - Executive Bio, Top Executies, and Transitions ...
View the organization profile of Teitur Trophics,Simon Molgaard, PhD, is co-inventor of key Teitur patents. Author of key neuroscience publications over the last 10 years. Has led research, …See details»
Teitur Trophics ApS - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore Teitur Trophics ApS with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Endocrinology and Metabolic Disease, Nervous System …See details»
Contact – Teiturtrophics
Teitur Trophics ApS Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Region Midtjylland, Denmark Email: [email protected]See details»
Teitur Trophics ApS, Financial Info, Board and Management, …
SECTOR KEY FIGURES Employees: 2Changes In Board and Management in last 6 months: Men: 0 Women: 0 GENDER BALANCE Year Month Board Management Operational …See details»
Teiturtrophics – Teiturtrophics
Sep 26, 2024 More than 200 million patients suffer from neurodegenerative disorders world-wide. Today, no treatments are available to prevent the relentless progression of neurodegeneration, affecting memory, movement and quality of …See details»
Teitur Trophics - VentureRadar
"Teitur Trophics is a biotech company, established in January 2020, aiming to treat chronic neurological disorders with a special focus on Huntington’s disease (HD). Through state-of-the …See details»
Teitur Trophics Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Teitur Trophics. See Teitur Trophics company profile and funding data.See details»
Our Team – Teiturtrophics
Edward Browne Chief Development Officer Ed has over 20 years experience in drug discovery and development, spanning big Pharma, CRO, biotech and consultancy roles supporting the …See details»
Teiturtrophics – Teiturtrophics
From the Sortilins family of receptors, Teitur has developed cyclic peptides with a unique potential for addressing key pathologies across several neurodegenerative disorders including …See details»
Teitur Trophics - Sunstone
These diseases impact memory, behaviour, movement and mood of millions of people around the globe and Teitur strives to improve the lives of these patients. https://teiturtrophics.com For …See details»
Board of Directors – Teiturtrophics
Sound Bioventures Before founding Sound Bioventures, Casper was a Senior Partner at Lundbeckfonden Ventures, where he worked for 12 years, and led investments and served as …See details»
Teitur Trophics Raises EUR 28M in Series A Financing to Advance …
Mar 14, 2023 For more information, please visit: www.TeiturTrophics.com About Sunstone Life Science Ventures Sunstone Life Science Ventures is an independent European venture …See details»
News – Teiturtrophics
Our CEO Simon Mølgaard was interviewed by Sejelas where he talks about Teitur Trophics and our commitment to developing novel treatments for treating patients suffering from …See details»
Board of Directors – Teiturtrophics
Casper Breum Sound Bioventures Before founding Sound Bioventures, Casper was a Senior Partner at Lundbeckfonden Ventures, where he worked for 12 years, and led investments and …See details»
Parkinson’s Disease – Teiturtrophics
Overview Parkinson’s disease (PD) occurs when brain cells that make dopamine, a chemical that coordinates movement, stop working or die. Because PD can cause tremor, slowness, …See details»
Our Science – Teiturtrophics
Huntington’s Huntington’s disease (HD) is a rare, inherited disease that causes the progressive breakdown (degeneration) of nerve cells in the brain. HD has a broad impact on a person’s …See details»